McKesson Corporation (FRA:MCK)

Germany flag Germany · Delayed Price · Currency is EUR
685.80
-22.00 (-3.11%)
At close: Dec 4, 2025
16.20%
Market Cap 86.17B
Revenue (ttm) 329.92B
Net Income (ttm) 3.44B
Shares Out n/a
EPS (ttm) 27.37
PE Ratio 25.07
Forward PE 19.91
Dividend 2.72 (0.40%)
Ex-Dividend Date Dec 1, 2025
Volume n/a
Average Volume 4
Open 685.80
Previous Close 707.80
Day's Range 685.80 - 685.80
52-Week Range 534.40 - 768.00
Beta n/a
RSI 37.10
Earnings Date Feb 4, 2026

About McKesson

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products. This segment also provides practice management, technology, clinical support, and business solutions to community-based oncology and other specialt... [Read more]

Industry Drugs, Drug Proprietaries, and Druggists' Sundries
Founded 1833
Employees 45,000
Stock Exchange Frankfurt Stock Exchange
Ticker Symbol MCK
Full Company Profile

Financial Performance

In 2024, McKesson's revenue was $359.05 billion, an increase of 16.22% compared to the previous year's $308.95 billion. Earnings were $3.30 billion, an increase of 9.76%.

Financial numbers in USD Financial Statements

News

There is no news available yet.